Clinical efficacy of iodine complex in SARS-CoV-2-infected patients with mild to moderate symptoms: study protocol for a randomized controlled trial

Clinical efficacy of iodine complex in SARS-CoV-2-infected patients with mild to moderate symptoms: study protocol for a randomized controlled trial

Abstract Background Coronavirus disease 2019 (COVID-19) caused by the novel coronavirus-infected millions globally. Despite a wide range of advised options for the treatment of COVID-19, a single strategy to tackle this pandemic remains elusive, thus far. That is why we are conducting a clinical tri...

Full description

Bibliographic Details
Main Authors: Sohaib Ashraf, Shoaib Ashraf, Moneeb Ashraf, Iqra Farooq, Rutaba Akmal, Muhammad Ahmad Imran, Larab Kalsoom, Sidra Ashraf, Sundas Rafique, Muhammad Ghufran, Muhammad Kiwan Akram, Sohaib-ur-Rehman, Muhammad Faisal Nadeem, Nazish Matti, Uzma Nasim Siddiqui, Ayesha Humayun, Qazi Abdul Saboor, Ali Ahmad, Muhammad Ashraf, Mateen Izhar, DOCTORS LOUNGE consortium
Format: Article
Language:English
Published: BMC 2022-01-01
Series:Trials
Subjects:
Iodine
COVID-19
SARS-CoV-2
Online Access:https://doi.org/10.1186/s13063-021-05848-8

Internet

https://doi.org/10.1186/s13063-021-05848-8

Similar Items